New paper demonstrates Adaptive’s revolutionary antibody discovery approach

Katey Owen

Katey Owen, PhD

Board Member

Katey Einterz Owen, PhD, joined our board of directors in 2021.  Dr. Owen has worked for the Bill & Melinda Gates Foundation since 2013, where she currently serves as Director, Vaccine Development and Director, Neglected Tropical Diseases, maintaining end-to-end responsibility for the Gates Foundation’s investments in these areas, including facilitation of the Foundation’s interactions with pharmaceutical companies.  Dr. Owen is active on the boards of The End Fund to end neglected diseases and GHIT, the Global Health Innovative Technology Fund.  Previously she held senior roles in product development, manufacturing, and commercialization at Merck & Co., Inc.  Prior to industry, Katey carried out academic research at the National Institute for Medical Research in London.  She earned her PhD in molecular virology and her BS in genetics from Purdue University.